|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jelovac D and Armstrong DK: Recent
progress in the diagnosis and treatment of ovarian cancer. CA
Cancer J Clin. 61:183–203. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Legge F, Ferrandina G, Salutari V and
Scambia G: Biological characterization of ovarian cancer:
Prognostic and therapeutic implications. Ann Oncol. 16 Suppl
4:iv95–101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pasquinelli AE: MicroRNAs and their
targets: Recognition, regulation and an emerging reciprocal
relationship. Nat Rev Genet. 13:271–282. 2012.PubMed/NCBI
|
|
5
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang H, Cao F, Li X, Miao HEJ, Xing J and
Fu CG: miR-320b suppresses cell proliferation by targeting c-Myc in
human colorectal cancer cells. BMC Cancer. 15:7482015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tai MC, Kajino T, Nakatochi M, Arima C,
Shimada Y, Suzuki M, Miyoshi H2, Yatabe Y3, Yanagisawa K and
Takahashi T: miR-342-3p regulates MYC transcriptional activity via
direct repression of E2F1 in human lung cancer. Carcinogenesis.
36:1464–1473. 2015.PubMed/NCBI
|
|
8
|
Matsuyama R, Okuzaki D, Okada M and
Oneyama C: MicroRNA-27b suppresses tumor progression by regulating
ARFGEF1 and focal adhesion signaling. Cancer Sci. 107:28–35. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu W, An J, Li K and Hou H: MiR-429
regulates gastric cancer cell invasiveness through ZEB proteins.
Tumour Biol. Oct 15–2015.(Epub ahead of print).
|
|
10
|
Li HT, Zhang H, Chen Y, Liu XF and Qian J:
MiR-423-3p enhances cell growth through inhibition of p21Cip1/Waf1
in colorectal cancer. Cell Physiol Biochem. 37:1044–1054. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu T, Liu L, Li J, Yan M, Lin H, Liu Y,
Chu D, Tu H, Gu A and Yao M: MiRNA-10a is upregulated in NSCLC and
may promote cancer by targeting PTEN. Oncotarget. 6:30239–30250.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Luo P, Fei J, Zhou J and Zhang W:
microRNA-126 suppresses PAK4 expression in ovarian cancer SKOV3
cells. Oncol Lett. 9:2225–2229. 2015.PubMed/NCBI
|
|
13
|
Guo J, Xia B, Meng F and Lou G: miR-137
suppresses cell growth in ovarian cancer by targeting AEG-1.
Biochem Biophys Res Commun. 441:357–363. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dong R, Liu X, Zhang Q, Jiang Z, Li Y, Wei
Y, Li Y, Yang Q, Liu J, Wei JJ, et al: miR-145 inhibits tumor
growth and metastasis by targeting metadherin in high-grade serous
ovarian carcinoma. Oncotarget. 5:10816–10829. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wen Z, Zhao S, Liu S, Liu Y, Li X and Li
S: MicroRNA-148a inhibits migration and invasion of ovarian cancer
cells via targeting sphingosine-1-phosphate receptor 1. Mol Med
Rep. 12:3775–3780. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu R, Liu F, Li L, Sun M and Chen K:
MiR-498 regulated FOXO3 expression and inhibited the proliferation
of human ovarian cancer cells. Biomed Pharmacother. 72:52–57. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fan Y, Fan J, Huang L, Ye M, Huang Z, Wang
Y, Li Q and Huang J: Increased expression of microRNA-196a predicts
poor prognosis in human ovarian carcinoma. Int J Clin Exp Pathol.
8:4132–4137. 2015.PubMed/NCBI
|
|
18
|
Liu N, Zhong L, Zeng J, Zhang X, Yang Q,
Liao D and Wang Y, Chen G and Wang Y: Upregulation of microRNA-200a
associates with tumor proliferation, CSCs phenotype and
chemosensitivity in ovarian cancer. Neoplasma. 62:550–559. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Niu K, Shen W, Zhang Y, Zhao Y and Lu Y:
MiR-205 promotes motility of ovarian cancer cells via targeting
ZEB1. Gene. 574:330–336. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song N, Liu H, Ma X and Zhang S: Placental
growth factor promotes metastases of ovarian cancer through
MiR-543-regulated MMP7. Cell Physiol Biochem. 37:1104–1112. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu T, Yuan J, Wang Y, Gong C, Xie Y and
Li H: MiR-661 contributed to cell proliferation of human ovarian
cancer cells by repressing INPP5J expression. Biomed Pharmacother.
75:123–128. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fonseca-Sanchéz MA, Pérez-Plasencia C,
Fernández-Retana J, Arechaga-Ocampo E, Marchat LA, Rodríguez-Cuevas
S, Bautista-Piña V, Arellano-Anaya ZE, Flores-Pérez A, Diaz-Chávez
J and López-Camarillo C: microRNA-18b is upregulated in breast
cancer and modulates genes involved in cell migration. Oncol Rep.
30:2399–2410. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang ZZ, Liu X, Wang DQ, Teng MK, Niu LW,
Huang AL and Liang Z: Hepatitis B virus and hepatocellular
carcinoma at the miRNA level. World J Gastroenterol. 17:3353–3358.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guo J, Miao Y, Xiao B, Huan R, Jiang Z,
Meng D and Wang Y: Differential expression of microRNA species in
human gastric cancer versus non-tumorous tissues. J Gastroenterol
Hepatol. 24:652–657. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen
XM and Gao HJ: Initial study of microRNA expression profiles of
colonic cancer without lymph node metastasis. J Dig Dis. 11:50–54.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Murakami Y, Tamori A, Itami S, Tanahashi
T, Toyoda H, Tanaka M, Wu W, Brojigin N, Kaneoka Y, Maeda A, et al:
The expression level of miR-18b in hepatocellular carcinoma is
associated with the grade of malignancy and prognosis. BMC Cancer.
13:992013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guan Y, Chen L, Bao Y, Li Z, Cui R, Li G
and Wang Y: Identification of low miR-105 expression as a novel
poor prognostic predictor for human glioma. Int J Clin Exp Med.
8:10855–10864. 2015.PubMed/NCBI
|
|
29
|
Dou H, Wang Y, Su G and Zhao S: Decreased
plasma let-7c and miR-152 as noninvasive biomarker for
non-small-cell lung cancer. Int J Clin Exp Med. 8:9291–9298.
2015.PubMed/NCBI
|
|
30
|
Cai K, Shen F, Cui JH, Yu Y and Pan HQ:
Expression of miR-221 in colon cancer correlates with prognosis.
Int J Clin Exp Med. 8:2794–2798. 2015.PubMed/NCBI
|
|
31
|
Husby S, Ralfkiaer U, Garde C, Zandi R, Ek
S, Kolstad A, Jerkeman M, Laurell A, Räty R, Pedersen LB, et al:
miR-18b overexpression identifies mantle cell lymphoma patients
with poor outcome and improves the MIPI-B prognosticator. Blood.
125:2669–2677. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Betel D, Wilson M, Gabow A, Marks DS and
Sander C: The microRNA.org resource: Targets and expression.
Nucleic Acids Res. 36:(Database issue). D149–D153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar
|
|
34
|
Ying H, Qu D, Liu C, Ying T, Lv J, Jin S
and Xu H: Chemoresistance is associated with Beclin-1 and PTEN
expression in epithelial ovarian cancers. Oncol Lett. 9:1759–1763.
2015.PubMed/NCBI
|
|
35
|
Cheaib B, Auguste A and Leary A: The
PI3K/Akt/mTOR pathway in ovarian cancer: Therapeutic opportunities
and challenges. Chin J Cancer. 34:4–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu H, Wang K, Liu W and Hao Q: PTEN
overexpression improves cisplatin-resistance of human ovarian
cancer cells through upregulating KRT10 expression. Biochem Biophys
Res Commun. 444:141–146. 2014. View Article : Google Scholar : PubMed/NCBI
|
